According to a 2025 survey conducted by the Prevent Cancer Foundation, only 51% of U.S. adults 21 and older say they have had ...

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer, NBC News reported. The test isn't meant to replace colonoscopies, but is ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

Colon cancer is the second-deadliest cancer in America. It's not deadly because it's particularly hard to treat or because oncologists are bad at spotting it. In large part, it's because people aren't ...

The first blood test to screen for colorectal cancer could be approved this year — raising the potential to drastically increase the number of people diagnosed with the second-highest cause of cancer ...

Huntsman Cancer Institute recommends all individuals start regular colorectal cancer screenings at age 45. Colorectal cancer screenings help detect colon and rectal cancer early when it is easier to ...

According to Cologuard, made by Wisconsin-based Exact Sciences, there are three primary reasons why you may receive a testing ...

Colorectal cancer was once considered primarily a disease of aging. But rates are now on the rise among younger adults. Since 2011, colon cancer rates among people younger than 50 have increased by ...

Colon cancer remains a significant health concern, particularly within the Black community, where the disease disproportionately affects individuals. A recent study led by researcher Adjoa ...

Dr. Bethany Malone has treated a lot of colorectal cancer patients. The youngest, not counting those with genetic conditions, ...

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating enthusiasm ...